Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

0QQ6

Roche (0QQ6)

Roche Holding Ag

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0QQ6

1

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
16/05/2024	07h00	UK Regulatory	[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity	LSE:0QQ6	Roche Holding Ag
15/05/2024	07h00	UK Regulatory	Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer	LSE:0QQ6	Roche Holding Ag
24/04/2024	07h00	UK Regulatory	[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-Produkte	LSE:0QQ6	Roche Holding Ag
24/04/2024	07h00	UK Regulatory	[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19	LSE:0QQ6	Roche Holding Ag
19/04/2024	07h00	UK Regulatory	FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer	LSE:0QQ6	Roche Holding Ag
17/04/2024	08h00	UK Regulatory	Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS	LSE:0QQ6	Roche Holding Ag
15/04/2024	07h00	UK Regulatory	[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study	LSE:0QQ6	Roche Holding Ag
11/04/2024	07h00	UK Regulatory	Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis	LSE:0QQ6	Roche Holding Ag
26/03/2024	17h45	UK Regulatory	Roche receives FDA approval for the first molecular test to screen for malaria in blood donors	LSE:0QQ6	Roche Holding Ag
12/03/2024	13h30	UK Regulatory	Roche Generalversammlung 2024	LSE:0QQ6	Roche Holding Ag
12/03/2024	13h30	UK Regulatory	Assemblée générale 2024 de Roche	LSE:0QQ6	Roche Holding Ag
12/03/2024	13h30	UK Regulatory	Roche Annual General Meeting 2024	LSE:0QQ6	Roche Holding Ag
05/03/2024	13h30	UK Regulatory	Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care	LSE:0QQ6	Roche Holding Ag
25/02/2024	20h00	UK Regulatory	New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies	LSE:0QQ6	Roche Holding Ag
16/02/2024	17h24	UK Regulatory	FDA approves Xolair as first and only medicine for children and adults with one or more food allergies	LSE:0QQ6	Roche Holding Ag
01/02/2024	07h03	UK Regulatory	New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)	LSE:0QQ6	Roche Holding Ag
01/02/2024	07h00	UK Regulatory	[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline	LSE:0QQ6	Roche Holding Ag
01/02/2024	07h00	UK Regulatory	[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft Guidance für 2023 und erzielt trotz stark rückläufigem COVID-19-Umsatz Verkaufswachstum von 1% (CER)	LSE:0QQ6	Roche Holding Ag
01/02/2024	07h00	UK Regulatory	[Annonce événementielle au sens de l’art. 53 RC] Roche dépasse les projections et affiche une croissance des ventes de 1 % (TCC) en 2023, malgré un net recul des ventes lié au COVID-19	LSE:0QQ6	Roche Holding Ag
23/10/2023	13h18	IH Market News	Monday’s Wall Street Highlights: Philips, Chevron, Textainer, Okta, Roivant, and more	LSE:0QQ6	Roche Holding Ag

Showing the most relevant articles for your search:LSE:0QQ6

1

NLBNPIT1WZ96 20240920 120

Decentralized Vulnerability Plat

NLBNPIT1TT40 20240621 750

SSGA SPDR Etfs Europe I (PK)

Silent Notary Token

Piedmont Lithium

Global Gold (PK)

NLBNPIT210Z7 20991231 98...

Spartan Acquisition Corp... (PK)

NLBNPIT1YKZ7 20991231 59...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen